Molecular action of androgens

Molecular and Cellular Endocrinology

Volumn 198, Issue 1-2, 2002, Pages 15-24

  Gobinet, J ^c   Poujol, N ^c   Sultan, Ch ^a,b,c  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b LAPEYRONIE HOSPITAL   (France)

^c INSERM   (France)

Author keywords

Androgen receptor; Cofactor; Structure; Transactivation regulation; Transcription factor

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; TRANSCRIPTION FACTOR;

BINDING AFFINITY; CONFERENCE PAPER; DNA SEQUENCE; GENE ACTIVATION; GENE TARGETING; GENE TRANSLOCATION; HORMONE ACTION; HUMAN; LIGAND BINDING; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ANDROGENS; BINDING SITES; CHROMOSOMES, HUMAN, X; HUMANS; LIGANDS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, ANDROGEN; TRANS-ACTIVATION (GENETICS);

EID: 12244273670     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00364-7     Document Type: Conference Paper

References (85)

1. Adachi S., Okuno M., Matsushima-Nishiwaki R., Takano Y., Kojima S., Friedman S.L., Moriwaki H., Okano Y. Phosphorylation of retinoid X receptor suppresses its ubiquitination in human hepatocellular carcinoma. Hepatology. 35:2002;332-340.
2. Berrevoets C.A., Doesburg P., Steketee K., Trapman J., Brinkmann A.O. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor 2). Mol. Endocrinol. 12:1998;1172-1183.
3. Black B.E., Holaska J.M., Rastinejad F., Paschal B.M. DNA binding domains in diverse nuclear receptors function as nuclear export signals. Curr. Biol. 11:2001;1749-1758.
4. Bourguet W., Ruff M., Bonnier D., Granger F., Boeglin M., Chambon P., Moras D., Gronemeyer H. Purification, functional characterization, and crystallization of the ligand binding domain of the retinoid X receptor. Protein Exp. Purif. 6:1995;604-608.
5. Bourguet W., Vivat V., Wurtz J.M., Chambon P., Gronemeyer H., Moras D. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol. Cell. 5:2000;289-298.
6. Brady M.E., Ozanne D.M., Gaughan L., Waite I., Cook S., Neal D.E., Robson C.N. Tip60 is a nuclear hormone receptor coactivator. J. Biol. Chem. 274:1999;17599-17604.
7. Brinkmann A.O., Jenster G., Ris-Stalpers C., van der Korput J.A., Bruggenwirth H.T., Boehmer A.L., Trapman J. Androgen receptor mutations. J. Steroid Biochem. Mol. Biol. 53:1995;443-448.
8. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.A., Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 389:1997;753-758.
9. Chen S., Wang J., Yu G., Liu W., Pearce D. Androgen and glucocorticoid receptor heterodimer formation. A possible mechanism for mutual inhibition of transcriptional activity. J. Biol. Chem. 272:1997;14087-14092.
10. Chen D., Ma H., Hong H., Koh S.S., Huang S.M., Schurter B.T., Aswad D.W., Stallcup M.R. Regulation of transcription by a protein methyltransferase. Science. 284:1999;2174-2177.
11. Dai J.L., Burnstein K.L. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA. Mol. Endocrinol. 10:1996;1582-1594.
12. Egea P.F., Mitschler A., Rochel N., Ruff M., Chambon P., Moras D. Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid. EMBO J. 19:2000;2592-2601.
13. Fabre S., Manin M., Pailhoux E., Veyssiere G., Jean C. Identification of a functional androgen response element in the promoter of the gene for the androgen-regulated aldose reductase-like protein specific to the mouse vas deferens. J. Biol. Chem. 269:1994;5857-5864.
14. Freedman L.P. Anatomy of the steroid receptor zinc finger region. Endocr. Rev. 13:1992;129-145.
15. Froesch B.A., Takayama S., Reed J.C. BAG-1L protein enhances androgen receptor function. J. Biol. Chem. 273:1998;11660-11666.
16. Frønsdal K., Engedal N., Slagsvold T., Saatcioglu F. CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1. J. Biol. Chem. 273:1998;31853-31859.
17. Fujimoto N., Yeh S., Kang H.Y., Inui S., Chang H.C., Mizokami A., Chang C. Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate. J. Biol. Chem. 274:1999;8316-8321.
18. Georget V., Lobaccaro J.M., Terouanne B., Mangeat P., Nicolas J.C., Sultan C. Trafficking of the androgen receptor in living cells with fused green fluorescent protein-androgen receptor. Mol. Cell. Endocrinol. 129:1997;17-26.
19. Giguere V. Orphan nuclear receptors: from gene to function. Endocr. Rev. 20:1999;689-725.
20. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:2000;121-141.
21. Gobinet J., Auzou G., Nicolas J.C., Sultan C., Jalaguier S. Characterization of the interaction between androgen receptor and a new transcriptional inhibitor, SHP. Biochemistry. 40:2001;15369-15377.
22. Gorlich D. Transport into and out of the cell nucleus. EMBO J. 17:1998;2721-2727.
23. Gross M., Liu B., Tan J., French F.S., Carey M., Shuai K. Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. Oncogene. 20:2001;3880-3887.
24. Haelens A., Verrijdt G., Schoenmakers E., Alen P., Peeters B., Rombauts W., Claessens F. The first exon of the human sc gene contains an androgen responsive unit and an interferon regulatory factor element. Mol. Cell. Endocrinol. 153:1999;91-102.
25. Hammer G.D., Krylova I., Zhang Y., Darimont B.D., Simpson K., Weigel N.L., Ingraham H.A. Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol. Cell. 3:1999;521-526.
26. Hayes S.A., Zarnegar M., Sharma M., Yang F., Peehl D.M., ten Dijke P., Sun Z. SMAD3 represses androgen receptor-mediated transcription. Cancer Res. 61:2001;2112-2118.
27. Holter E., Kotaja N., Makela S., Strauss L., Kietz S., Janne O.A., Gustafsson J.A., Palvimo J.J., Treuter E. Inhibition of androgen receptor (AR) function by the reproductive orphan nuclear receptor DAX-1. Mol. Endocrinol. 16:2002;515-528.
28. Hsiao P.W., Chang C. Isolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells. J. Biol. Chem. 274:1999;22373-22379.
29. Hsiao P.W., Lin D.L., Nakao R., Chang C. The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator. J. Biol. Chem. 274:1999;20229-20234.
30. Ikonen T., Palvimo J.J., Janne O.A. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J. Biol. Chem. 272:1997;29821-29828.
31. Johansson L., Thomsen J.S., Damdimopoulos A.E., Spyrou G., Gustafsson J.A., Treuter E. The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERalpha and ERbeta. J. Biol. Chem. 274:1999;345-353.
32. Kang H.Y., Yeh S., Fujimoto N., Chang C. Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor. J. Biol. Chem. 274:1999;8570-8576.
33. Ko L., Cardona G.R., Henrion-Caude A., Chin W.W. Identification and characterization of a tissue-specific coactivator, GT198, that interacts with the DNA-binding domains of nuclear receptors. Mol. Cell. Biol. 22:2002;357-369.
34. Kotaja N., Aittomäki S., Silvennoinen O., Palvimo J.J., Jänne O.A. ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation. Mol. Endocrinol. 14:2000;1986-2000.
35. Kuil C.W., Mulder E. Effects of androgens and antiandrogens on the conformation of the androgen receptor. Ann. New York Acad. Sci. 761:1995;351-354.
36. Kuiper G.G., Brinkmann A.O. Phosphotryptic peptide analysis of the human androgen receptor: detection of a hormone-induced phosphopeptide. Biochemistry. 34:1995;1851-1857.
37. Lee Y.F., Shyr C.R., Thin T.H., Lin W.J., Chang C. Convergence of two repressors through heterodimer formation of androgen receptor and testicular orphan receptor-4: A unique signaling pathway in the steroid receptor superfamily [In Process Citation]. Proc. Natl. Acad. Sci. USA. 96:1999;14724-14729.
38. Lee D.K., Duan H.O., Chang C. From androgen receptor to the general transcription factor TFIIH. Identification of cdk activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivator. J. Biol. Chem. 275:2000;9308-9313.
39. Lin H.K., Yeh S., Kang H.Y., Chang C. Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Proc. Natl. Acad. Sci. USA. 98:2001;7200-7205.
40. Lobaccaro J.M., Poujol N., Chiche L., Lumbroso S., Brown T.R., Sultan C. Molecular modeling and in vitro investigations of the human androgen receptor DNA-binding domain: application for the study of two mutations. Mol. Cell. Endocrinol. 116:1996;137-147.
41. Lu M.L., Schneider M.C., Zheng Y., Zhang X., Richie J.P. Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J. Biol. Chem. 276:2001;13442-13451.
42. Markus S.M., Taneja S.S., Logan S.K., Li W., Ha S., Hittelman A.B., Rogatsky I., Garabedian M.J. Identification and characterization of ART-27, a novel coactivator for the androgen receptor N terminus. Mol. Biol. Cell. 13:2002;670-682.
43. Matias P.M., Donner P., Coelho R., Thomaz M., Peixoto C., Macedo S., Otto N., Joschko S., Scholz P., Wegg A., Basler S., Schafer M., Egner U., Carrondo M.A. Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. J. Biol. Chem. 275:2000;26164-26171.
44. McEwan I.J., Gustafsson J. Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF. Proc. Natl. Acad. Sci. USA. 94:1997;8485-8490.
45. McKenna N.J., Lanz R.B., O'Malley B.W. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20:1999;321-344.
46. Moilanen A.M., Karvonen U., Poukka H., Jänne O.A., Palvimo J.J. Activation of androgen receptor function by a novel nuclear protein kinase. Mol. Biol. Cell. 9:1998;2527-2543.
47. Moilanen A.M., Poukka H., Karvonen U., Häkli M., Jänne O.A., Palvimo J.J. Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription. Mol. Cell. Biol. 18:1998;5128-5139.
48. Moilanen A.M., Karvonen U., Poukka H., Yan W., Toppari J., Jänne O.A., Palvimo J.J. A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins. J. Biol. Chem. 274:1999;3700-3704.
49. Müller J.M., Isele U., Metzger E., Rempel A., Moser M., Pscherer A., Breyer T., Holubarsch C., Buettner R., Schule R. FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J. 19:2000;359-369.
50. Ng H.H., Bird A. Histone deacetylases: silencers for hire. Trends Biochem. Sci. 25:2000;121-126.
51. Nguyen D., Steinberg S.V., Rouault E., Chagnon S., Gottlieb B., Pinsky L., Trifiro M., Mader S. A G577R mutation in the human AR P box results in selective decreases in DNA binding and in partial androgen insensitivity syndrome. Mol. Endocrinol. 15:2001;1790-1802.
52. Nirdé P., Georget V., Térouanne B., Galifer R.B., Belon C., Sultan C. Quantification of androgen receptor messenger RNA from genital skin fibroblasts by reverse transcription-competitive polymerase chain reaction. J. Steroid Biochem. Mol. Biol. 66:1998;35-43.
53. Orphanides G., Reinberg D. A unified theory of gene expression. Cell. 108:2002;439-451.
54. Park J.J., Irvine R.A., Buchanan G., Koh S.S., Park J.M., Tilley W.D., Stallcup M.R., Press M.F., Coetzee G.A. Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor. Cancer Res. 60:2000;5946-5949.
55. Petre C.E., Wetherill Y.B., Danielsen M., Knudsen K.E. Cyclin D1: mechanism and consequence of androgen receptor co-repressor activity. J. Biol. Chem. 277:2002;2207-2215.
56. Pike A.C., Brzozowski A.M., Hubbard R.E., Bonn T., Thorsell A.G., Engstrom O., Ljunggren J., Gustafsson J.A., Carlquist M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J. 18:1999;4608-4618.
57. Poujol N., Lobaccaro J.M., Chiche L., Lumbroso S., Sultan C. Functional and structural analysis of R607Q and R608K androgen receptor substitutions associated with male breast cancer. Mol. Cell. Endocrinol. 130:1997;43-51.
58. Poujol N., Wurtz J.M., Tahiri B., Lumbroso S., Nicolas J.C., Moras D., Sultan C. Specific recognition of androgens by their nuclear receptor. A structure-function study. J. Biol. Chem. 275:2000;24022-24031.
59. Poukka H., Aarnisalo P., Karvonen U., Palvimo J.J., Janne O.A. Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. J. Biol. Chem. 274:1999;19441-19446.
60. Quigley C.A., Debellis A., Marschke K.B., Elawady M.K., Wilson E.M., French F.S. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr. Rev. 16:1995;271-321.
61. Renaud J.P., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., Moras D. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature. 378:1995;681-689.
62. Robyr D., Wolffe A.P., Wahli W. Nuclear hormone receptor coregulators in action: diversity for shared tasks. Mol. Endocrinol. 14:2000;329-347.
63. Roche P.J., Hoare S.A., Parker M.G. A consensus DNA-binding site for the androgen receptor. Mol. Endocrinol. 6:1992;2229-2235.
64. Rochel N., Wurtz J.M., Mitschler A., Klaholz B., Moras D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell. 5:2000;173-179.
65. Sack J.S., Kish K.F., Wang C., Attar R.M., Kiefer S.E., An Y., Wu G.Y., Scheffler J.E., Salvati M.E., Krystek S.R. Jr, Weinmann R., Einspahr H.M. Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc. Natl. Acad. Sci. USA. 98:2001;4904-4909.
66. Schoenmakers E., Verrijdt G., Peeters B., Verhoeven G., Rombauts W., Claessens F. Differences in DNA binding characteristics of the androgen and glucocorticoid receptors can determine hormone-specific responses. J. Biol. Chem. 275:2000;12290-12297.
67. Seol W., Hanstein B., Brown M., Moore D.D. Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner). Mol. Endocrinol. 12:1998;1551-1557.
68. Sharma M., Zarnegar M., Li X., Lim B., Sun Z. Androgen receptor interacts with a novel MYST protein, HBO1. J. Biol. Chem. 275:2000;35200-35208.
69. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., Greene G.L. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 95:1998;927-937.
70. Supakar P.C., Song C.S., Jung M.H., Slomczynska M.A., Kim J.M., Vellanoweth R.L., Chatterjee B., Roy A.K. A novel regulatory element associated with age-dependent expression of the rat androgen receptor gene. J. Biol. Chem. 268:1993;26400-264008.
71. Tahiri B., Auzou G., Nicolas J.C., Sultan C., Lupo B. Participation of critical residues from the extreme C-terminal end of the human androgen receptor in the ligand binding function. Biochemistry. 40:2001;8431-8437.
72. Takahashi K., Taira T., Niki T., Seino C., Iguchi-Ariga S.M., Ariga H. DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. J. Biol. Chem. 276:2001;37556-37563.
73. Tan J., Hall S.H., Hamil K.G., Grossman G., Petrusz P., Liao J., Shuai K., French F.S. Protein inhibitor of activated STAT-1 (signal transducer and activator of transcription-1) is a nuclear receptor coregulator expressed in human testis. Mol. Endocrinol. 14:2000;14-26.
74. Tanenbaum D.M., Wang Y., Williams S.P., Sigler P.B. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc. Natl. Acad. Sci. USA. 95:1998;5998-6003.
75. Tremblay G.B., Tremblay A., Labrie F., Giguere V. Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex. Mol. Cell. Biol. 19:1999;1919-1927.
76. Uppenberg J., Svensson C., Jaki M., Bertilsson G., Jendeberg L., Berkenstam A. Crystal structure of the ligand binding domain of the human nuclear receptor PPARgamma. J. Biol. Chem. 273:1998;31108-31112.
77. Veldscholte J., Berrevoets C.A., Zegers N.D., van der Kwast T.H., Grootegoed J.A., Mulder E. Hormone-induced dissociation of the androgen receptor-heat-shock protein complex: use of a new monoclonal antibody to distinguish transformed from nontransformed receptors. Biochemistry. 31:1992;7422-7430.
78. Verrijdt G., Schoenmakers E., Haelens A., Peeters B., Verhoeven G., Rombauts W., Claessens F. Change of specificity mutations in androgen-selective enhancers. Evidence for a role of differential DNA binding by the androgen receptor. J. Biol. Chem. 275:2000;12298-12305.
79. Wang X., Yeh S., Wu G., Hsu C.L., Wang L., Chiang T., Yang Y., Guo Y., Chang C. Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cells. J. Biol. Chem. 276:2001;40417-40423.
80. Xu L., Glass C.K., Rosenfeld M.G. Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9:1999;140-147.
81. Yamamoto A., Hashimoto Y., Kohri K., Ogata E., Kato S., Ikeda K., Nakanishi M. Cyclin E as a coactivator of the androgen receptor. J. Cell. Biol. 150:2000;873-880.
82. Yang F., Li X., Sharma M., Zarnegar M., Lim B., Sun Z. Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6. J. Biol. Chem. 276:2001;15345-15353.
83. Yeh S., Chang C. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc. Natl. Acad. Sci. USA. 93:1996;5517-5521.
84. Yeh S., Miyamoto H., Nishimura K., Kang H., Ludlow J., Hsiao P., Wang C., Su C., Chang C. Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells. Biochem. Biophys. Res. Commun. 248:1998;361-367.
85. Yu X., Li P., Roeder R.G., Wang Z. Inhibition of Androgen Receptor-Mediated Transcription by Amino-Terminal Enhancer of split. Mol. Cell. Biol. 21:2001;4614-4625.